STOCK TITAN

[Form 4] Air Products & Chemicals, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Howard I. Ungerleider, a director of Air Products & Chemicals, Inc. (APD), reported on Form 4 that on 09/01/2025 he acquired 226.5493 phantom deferred stock units under the company’s director Deferred Compensation Program. The units are convertible into an equal number of common shares and are payable after board service ends, either as a lump sum or in up to ten installments as previously elected. The report shows a reference price of $294.27 and lists 226.5493 shares beneficially owned following the transaction, held directly. The filing was signed on 09/02/2025 by Andrea I. Rennig as attorney-in-fact.

Howard I. Ungerleider, membro del consiglio di Air Products & Chemicals, Inc. (APD), ha dichiarato nel Modulo 4 che il 01/09/2025 ha acquisito 226,5493 unità phantom di stock differito nell'ambito del Programma di Compensazione Differita per i direttori della società. Le unità sono convertibili in un pari numero di azioni ordinarie e saranno corrisposte alla cessazione del mandato consiliare, con possibilità di ricevere l'importo in un'unica soluzione o in un massimo di dieci rate, come già scelto. Il rapporto indica un prezzo di riferimento di $294,27 e riporta la proprietà beneficiaria di 226,5493 azioni dopo la transazione, detenute direttamente. Il documento è stato firmato il 02/09/2025 da Andrea I. Rennig in qualità di procuratore.

Howard I. Ungerleider, miembro del directorio de Air Products & Chemicals, Inc. (APD), informó en el Formulario 4 que el 01/09/2025 adquirió 226,5493 unidades diferidas fantasma bajo el Programa de Compensación Diferida para directores de la compañía. Las unidades son convertibles en un número igual de acciones ordinarias y se pagarán al finalizar el servicio en la junta, ya sea en un solo pago o en hasta diez cuotas según la elección previa. El informe muestra un precio de referencia de $294,27 y lista 226,5493 acciones de propiedad beneficiaria tras la operación, mantenidas directamente. La presentación fue firmada el 02/09/2025 por Andrea I. Rennig como apoderada.

Howard I. Ungerleider, Air Products & Chemicals, Inc.(APD) 이사의 Howard I. Ungerleider는 Form 4에 2025년 09/01에 회사 이사 연봉연기보상제도(Director Deferred Compensation Program)에 따라 226.5493개의 팬텀 연기 주식 단위를 취득했다고 보고했습니다. 해당 단위는 동일 수의 보통주로 전환 가능하며, 이사회 임기 종료 시 일시금 또는 이전에 선택한 대로 최대 10회 분할로 지급됩니다. 보고서에는 기준 가격이 $294.27로 기재되어 있고, 거래 후 226.5493주의 실소유(beneficially owned)가 직접 보유 중인 것으로 표시되어 있습니다. 서류는 2025년 09/02에 Andrea I. Rennig이 대리인(Attorney‑in‑fact)으로 서명했습니다.

Howard I. Ungerleider, administrateur d'Air Products & Chemicals, Inc. (APD), a déclaré sur le Formulaire 4 que le 01/09/2025 il a acquis 226,5493 unités d'actions différées fictives dans le cadre du programme de rémunération différée des administrateurs de la société. Ces unités sont convertibles en un nombre égal d'actions ordinaires et seront payées à la fin du mandat au conseil, soit en un seul versement, soit en jusqu'à dix échéances, conformément au choix antérieur. Le rapport indique un prix de référence de 294,27 $ et mentionne 226,5493 actions détenues à titre bénéficiaire après la transaction, détenues directement. Le dépôt a été signé le 02/09/2025 par Andrea I. Rennig en qualité de mandataire.

Howard I. Ungerleider, ein Direktor von Air Products & Chemicals, Inc. (APD), berichtete im Formular 4, dass er am 01.09.2025 226,5493 Phantom‑Deferred‑Stock‑Einheiten im Rahmen des Deferred‑Compensation‑Programms für Direktoren erworben hat. Die Einheiten sind in die gleiche Anzahl von Stammaktien umwandelbar und werden nach Beendigung der Vorstandstätigkeit ausgezahlt, entweder als Einmalbetrag oder in bis zu zehn Raten entsprechend der zuvor getroffenen Wahl. Der Bericht nennt einen Referenzpreis von $294,27 und führt nach der Transaktion 226,5493 begünstigt gehaltene Aktien auf, die direkt gehalten werden. Die Einreichung wurde am 02.09.2025 von Andrea I. Rennig als Bevollmächtigte unterzeichnet.

Positive
  • Director received 226.5493 phantom units under the Deferred Compensation Program, preserving long-term alignment with shareholders
  • Units convert one-for-one to common stock, providing clear linkage between deferred compensation and equity
Negative
  • None.

Insights

TL;DR: Routine director deferred-compensation award; records receipt of phantom units convertible to shares after service.

The filing documents a non-cash grant under the issuer’s Deferred Compensation Program for Directors. The reported 226.5493 phantom units are payable in common stock after the director’s service ends, consistent with long-term, equity-linked director pay practices. There is no indication of open-market purchases, sales, or changes in board composition in this filing. For governance monitoring, this is a disclosure of standard deferred equity accruals rather than an active trading event by the director.

TL;DR: Disclosure shows issuance of deferred stock units at a referenced price, reflecting compensation deferral mechanics.

The Form 4 specifies that Phantom Stock units were acquired on 09/01/2025 and are convertible one-for-one into common shares when paid. The filing notes a price reference of $294.27, though the entry clarifies price is not applicable to the security type. The payment options—lump sum or up to ten installments—are noted, which affects the timing of share delivery but not immediate share dilution. This is a standard director compensation record with limited immediate market impact based on the filed information.

Howard I. Ungerleider, membro del consiglio di Air Products & Chemicals, Inc. (APD), ha dichiarato nel Modulo 4 che il 01/09/2025 ha acquisito 226,5493 unità phantom di stock differito nell'ambito del Programma di Compensazione Differita per i direttori della società. Le unità sono convertibili in un pari numero di azioni ordinarie e saranno corrisposte alla cessazione del mandato consiliare, con possibilità di ricevere l'importo in un'unica soluzione o in un massimo di dieci rate, come già scelto. Il rapporto indica un prezzo di riferimento di $294,27 e riporta la proprietà beneficiaria di 226,5493 azioni dopo la transazione, detenute direttamente. Il documento è stato firmato il 02/09/2025 da Andrea I. Rennig in qualità di procuratore.

Howard I. Ungerleider, miembro del directorio de Air Products & Chemicals, Inc. (APD), informó en el Formulario 4 que el 01/09/2025 adquirió 226,5493 unidades diferidas fantasma bajo el Programa de Compensación Diferida para directores de la compañía. Las unidades son convertibles en un número igual de acciones ordinarias y se pagarán al finalizar el servicio en la junta, ya sea en un solo pago o en hasta diez cuotas según la elección previa. El informe muestra un precio de referencia de $294,27 y lista 226,5493 acciones de propiedad beneficiaria tras la operación, mantenidas directamente. La presentación fue firmada el 02/09/2025 por Andrea I. Rennig como apoderada.

Howard I. Ungerleider, Air Products & Chemicals, Inc.(APD) 이사의 Howard I. Ungerleider는 Form 4에 2025년 09/01에 회사 이사 연봉연기보상제도(Director Deferred Compensation Program)에 따라 226.5493개의 팬텀 연기 주식 단위를 취득했다고 보고했습니다. 해당 단위는 동일 수의 보통주로 전환 가능하며, 이사회 임기 종료 시 일시금 또는 이전에 선택한 대로 최대 10회 분할로 지급됩니다. 보고서에는 기준 가격이 $294.27로 기재되어 있고, 거래 후 226.5493주의 실소유(beneficially owned)가 직접 보유 중인 것으로 표시되어 있습니다. 서류는 2025년 09/02에 Andrea I. Rennig이 대리인(Attorney‑in‑fact)으로 서명했습니다.

Howard I. Ungerleider, administrateur d'Air Products & Chemicals, Inc. (APD), a déclaré sur le Formulaire 4 que le 01/09/2025 il a acquis 226,5493 unités d'actions différées fictives dans le cadre du programme de rémunération différée des administrateurs de la société. Ces unités sont convertibles en un nombre égal d'actions ordinaires et seront payées à la fin du mandat au conseil, soit en un seul versement, soit en jusqu'à dix échéances, conformément au choix antérieur. Le rapport indique un prix de référence de 294,27 $ et mentionne 226,5493 actions détenues à titre bénéficiaire après la transaction, détenues directement. Le dépôt a été signé le 02/09/2025 par Andrea I. Rennig en qualité de mandataire.

Howard I. Ungerleider, ein Direktor von Air Products & Chemicals, Inc. (APD), berichtete im Formular 4, dass er am 01.09.2025 226,5493 Phantom‑Deferred‑Stock‑Einheiten im Rahmen des Deferred‑Compensation‑Programms für Direktoren erworben hat. Die Einheiten sind in die gleiche Anzahl von Stammaktien umwandelbar und werden nach Beendigung der Vorstandstätigkeit ausgezahlt, entweder als Einmalbetrag oder in bis zu zehn Raten entsprechend der zuvor getroffenen Wahl. Der Bericht nennt einen Referenzpreis von $294,27 und führt nach der Transaktion 226,5493 begünstigt gehaltene Aktien auf, die direkt gehalten werden. Die Einreichung wurde am 02.09.2025 von Andrea I. Rennig als Bevollmächtigte unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ungerleider Howard I

(Last) (First) (Middle)
1940 AIR PRODUCTS BLVD.

(Street)
ALLENTOWN PA 18106-5500

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Air Products & Chemicals, Inc. [ APD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock(1) $0.0000(2) 09/01/2025 A 226.5493 (3) (3) Common Stock 226.5493 $294.27 226.5493 D
Explanation of Responses:
1. Phantom deferred stock units (Units) acquired under the Air Products Stock Account of the issuer's Deferred Compensation Program for Directors, under the Company's Long-Term Incentive Plan.
2. Not applicable to this security
3. These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance.
Andrea I. Rennig as Attorney in Fact 09/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did APD director Howard Ungerleider report on Form 4?

He reported acquisition of 226.5493 phantom deferred stock units on 09/01/2025 under the company's director Deferred Compensation Program.

When are the phantom units payable and how are they paid?

The units are payable after service on the company's Board ends and may be paid as a lump sum or in up to ten installments as elected.

How many shares does the Form 4 show beneficially owned after the transaction for APD?

The Form 4 shows 226.5493 shares beneficially owned following the reported transaction, held directly.

What price is shown on the Form 4 for the phantom units?

The filing references $294.27, and notes that price is not applicable to this security type, which is a deferred unit.

Who signed the Form 4 and when was it signed?

Andrea I. Rennig signed as attorney-in-fact on 09/02/2025.
Air Prods & Chems Inc

NYSE:APD

APD Rankings

APD Latest News

APD Latest SEC Filings

APD Stock Data

65.46B
221.66M
0.4%
94.4%
2.28%
Specialty Chemicals
Industrial Inorganic Chemicals
Link
United States
ALLENTOWN